Navigation Links
Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients
Date:8/29/2010

WILMINGTON, Del., Aug. 29 /PRNewswire-FirstCall/ -- A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute Coronary Syndromes (ACS) patients who received the investigational oral antiplatelet treatment, ticagrelor (BRILINTA™), were maintained, whether or not they had the genetic variability that has been previously shown to affect a patient's response to clopidogrel. The substudy is the first to look at both efficacy and bleeding endpoints of ACS patients treated with ticagrelor who carry variations in the CYP2C19 and ABCB1 genes. The data were presented today at the European Society of Cardiology (ESC) congress in Stockholm, Sweden and simultaneously published in The Lancet.    

(Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO)

CYP2C19

Regardless of the CYP2C19 genotype, the primary outcome occurred less often with ticagrelor versus clopidogrel (interaction p=0.46). Ticagrelor event rates were 8.6% per year in carriers  and 8.8% per year in non-carriers of CYP2C19 loss-of-function genotype. For clopidogrel patients that carried the CYP2C19 loss-of-function alleles, there was a 11.2% per year event rate, compared to 10.0% per year for patients without the loss of function allele. Similar to the overall PLATO study, total major bleeding did not significantly differ between ticagrelor and clopidogrel regardless of CYP2C19 genotype.

ABCB1

The genetic substudy also investigated ticagrelor and clopidogrel treatment outcomes in the three genetic groupings of the ABCB1 gene group; these were defined as high, intermediate and low expressions of ABCB1, respectively.  The primary efficacy event rates for ticagrelor were: 9.5% p
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Genetics Determine Optimal Drug Dose of Common Anticoagulant
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
6. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
7. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
11. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 26, 2015 ... (Filter, Bottle washer, Filler, Capper, Blow molder, Shrink ... Application (Still, Flavored, Sparkling) & Region - Trends ... and segments the bottled water processing market with ... in terms of value. It also identifies the ...
(Date:2/26/2015)... Feb. 26, 2015 People with psoriasis ... opportunity to participate in research that aims to ... independent U.S. psoriasis registry begins recruiting patients in ... with the National Psoriasis Foundation and Corrona, LLC, ... secukinumab, a new biologic medication by Novartis Pharmaceuticals ...
(Date:2/26/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the Cowen and Company 35 th Annual Health Care ... time from the Boston Marriott Copley Place. A live webcast ... A replay will be available approximately one hour after the ...
Breaking Medicine Technology:Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
... in Accelerated Payments of $8.5 Million -, ... MEMY ) today announced that it has ... to expand the,Phase 2 development program for R3487/MEM ... Pharmaceuticals is currently,conducting a Phase 2 trial of ...
... WASHINGTON, Sept. 17 The Department of,Justice announced ... by the CEO,Roundtable on Cancer (CRC) to develop ... potential new cancer treatments. The Department said,the language ... be used to help,increase efficiency in contract negotiations, ...
Cached Medicine Technology:Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program 2Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program 3Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program 4Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2
(Date:2/27/2015)... (PRWEB) February 27, 2015 With Spring’s wet ... keep the condition of their crawl spaces in mind. The ... of the most common FAQs regarding crawl space conditions and ... an answer to owners that are confused as to how ... that, “One of the most common ways is through cracks ...
(Date:2/27/2015)... 2015 Prescription Drug “Take-Back” events ... Enforcement Agency (DEA). Today, local law ... utilize the “Take-Back” guidelines for the proper disposal ... Eufaula Prescription Drug Disposal Event , The McInstosh ... Eufaula, Oklahoma as the “Take-Back” site for the ...
(Date:2/27/2015)... According to a Feb. 12, 2015 news release by ... cancer by killing cancer stem cells, has received orphan drug ... use in the treatment of mesothelioma.* According to the release, ... the development of drugs for the treatment of rare diseases. ... said Melinda Helbock, Founder of The Law Office of Melinda ...
(Date:2/27/2015)... The report analyzes the primary growth factors, ... disease market. It also assesses key players in the ... investments. , Celiac disease is an autoimmune disease that ... Celiac disease often has a genetic predisposition. According to ... by celiac disease across the globe. When gluten, a ...
(Date:2/27/2015)... A fireplace can cause the average home ... through the chimney’s flue when the fireplace is not in ... has solved with the introduction of a new small fireplace ... measuring 18" in diameter when inflated. It is quickly and ... the damper. This size unit fits into round dampers, which ...
Breaking Medicine News(10 mins):Health News:Crawl Space FAQs are Answered in Clean Crawls Latest Article 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:New DraftStopper from Tamarack Technologies Stops Heat Loss When Fireplace Not in Use 2
... Prentke Romich Company (PRC),the leading manufacturer of Alternative ... disabilities, has selected Acapela High,Quality voices to speech ... , Smart, ... new generation,communication device for children and adults who ...
... Growing number with genetic, familial susceptibilities opt for double mastectomy ... of Dallas, had the first cyst in her breast removed ... 19. , By the time she found the third lump, ... breast cancer (after being diagnosed at 55) and her mother ...
... 3 NewCardio, Inc.,(OTC Bulletin Board: NWCI) a cardiac ... a restructure of the going-forward terms of,its December 27, ... investors,in the transaction have exercised a portion of their ... sheet. This will extend the,Company,s cash reserves to ...
... guide, emphasizing a long-term, common sense approach to dieting. , ... ... NextAdvisor.com , the trusted, independent source for comparing the most valuable ... Common Sense Dieter,s Guide," a free guide filled with useful ...
... ON-HAND™ product offering, announcing the availability of their trusted point-of-care ... ... Hudson, OH (PRWEB) December 3, 2008 -- ... has released applications for the iPhone and the iPod touch. ...
... Bupa Asia Pacific Managing Director Dean Holden today announced that Mr ... company. , ... Melbourne, VIC (PRWEB) December 3, 2008 ... Mr Richard Bowden had officially taken over as Managing Director of ...
Cached Medicine News:Health News:Accessibility: Acapela Group Voice Enables Vantage Lite Innovative AAC Dedicated Device 2Health News:More High-Risk Women Preempt Breast Cancer 2Health News:More High-Risk Women Preempt Breast Cancer 3Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 2Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 3Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 4Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 5Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 6Health News:NextAdvisor.com Launches "Lose the Weight this Year: A Common Sense Dieter's Guide" 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 2Health News:Lexi-Comp Databases Now Available for the iPhone™ and iPod touch 3Health News:New Managing Director for Bupa Australia 2
... shelves. Over-sized compressor. Triple pane thermal ... Self-Contained System No plumbing required. Equipped ... Year Warranty on Parts & Labor and an ... Also available as a chromatography unit which includes ...
... Large Capacity Refigerators from Taylor-Wharton enables you ... samples at liquid-nitrogen temperature. Seven different unit ... are available to satisfy a broad range ... models are also available, providing reduced unit ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: